Taiwan Liposome Company, Ltd. Unsponsored ADR EBITDA 2019-2021 | TLC
Taiwan Liposome Company, Ltd. Unsponsored ADR ebitda from 2019 to 2021. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Taiwan Liposome Company, Ltd. Unsponsored ADR Annual EBITDA (Millions of US $) |
|
|---|---|
| 2020 | $-33 |
| 2019 | $-24 |
| 2018 | $-28 |
| 2017 | $-28 |
| Taiwan Liposome Company, Ltd. Unsponsored ADR Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2021-06-30 | $-2 |
| 2021-03-31 | $-7 |
| 2020-12-31 | $-11 |
| 2020-09-30 | $-8 |
| 2020-06-30 | $-8 |
| 2020-03-31 | $-7 |
| 2019-12-31 | $-9 |
| 2019-09-30 | $-5 |
| 2019-06-30 | $-7 |
| 2019-03-31 | $-3 |
| 2018-12-31 | $-9 |
| 2018-09-30 | $-6 |
| 2018-06-30 | $-7 |
| 2018-03-31 | $-5 |
